Ever Supreme Bio Technology Co (6712.TWO) Stock Price
Ever Supreme Bio Technology Co Price
Revenue has compounded at 113.3% per year over the past 6 years to 1.02 B TWD. Earnings per share have declined at 0.0% per year over the last 4 years. Ever Supreme Bio Technology Co's net margin stands at 42.2%, down from 84.2% several years earlier. Ever Supreme Bio Technology Co currently offers a dividend yield of about 2.82%. The payout ratio is around 90% of earnings. The dividend has grown at 7.4% per year over the past 3 years. Analysts set a median price target of 204.00 TWD, implying 29.9% above the current price. Of 10 analysts, 8 rate the stock a buy — an overall Buy consensus.
Ever Supreme Bio Technology Co stock price
Ever Supreme Bio Technology Co business model & stock analysis
Frequently asked questions about Ever Supreme Bio Technology Co
Analysts currently set an average price target of 204.00 TWD for the Ever Supreme Bio Technology Co stock (median: 204.00 TWD), implying +29.1 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Ever Supreme Bio Technology Co stock: 8 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Ever Supreme Bio Technology Co to generate revenue of 1.10 B TWD and earnings per share of 6.21 TWD.
Converted at the current exchange rate, the Ever Supreme Bio Technology Co share trades at 4.36 EUR (157.00 TWD).
The expected revenue of Ever Supreme Bio Technology Co is 1.10 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Ever Supreme Bio Technology Co is 544.21 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Ever Supreme Bio Technology Co is currently 25.27. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ever Supreme Bio Technology Co stock.
The price-to-sales ratio (P/S) of Ever Supreme Bio Technology Co is currently 12.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ever Supreme Bio Technology Co stock.
The Eulerpool Quality Score for Ever Supreme Bio Technology Co is 4/10.
The ISIN of Ever Supreme Bio Technology Co is TW0006712003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Ever Supreme Bio Technology Co is 6712.TWO. The ticker symbol is used to trade Ever Supreme Bio Technology Co shares on the stock exchange.
Ever Supreme Bio Technology Co stock
Ever Supreme Bio Technology Co Peer Group
Ever Supreme Bio Technology Co FIGI
All fundamentals and in-depth analysis of Ever Supreme Bio Technology Co
Our stock analysis for Ever Supreme Bio Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ever Supreme Bio Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.